Fundraising Fox
/Companies
Sign in

Creasallis

4 known investors

Find your way into Creasallis

Each arrow is one introduction. Sign up to fill in the first one.

369 people can intro you to Zahra

Ask David Birch to introduce you to Zahra Jawad

You →David · together at HM Revenue & Customs →Zahra

Sign up to find every way you can get introduced to Creasallis

  • Your email: who you already know at Creasallis, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Creasallis team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Creasallis develops CreaTap, a patented "plug-and-play" antibody modification technology that improves the penetration of antibody-based drugs into solid tumours, applicable to monoclonal, bispecific, and antibody-drug conjugates. It serves biopharmaceutical companies developing oncology therapeutics and is also building its own suite of antibody therapeutics with enhanced tumour penetration.

Biotech

Founders & leadership

ZJZahra Jawad
Zahra JawadFounderZahra Jawad holds a PhD in biochemistry and has over 15 years of experience in antibody therapeutics and protein engineering, with expertise in cell culture and high-throughput screening. She is founder and CEO of Creasallis, which develops CreaTap, a patented technology for modifying antibodies to improve penetration into solid tumours.

Investors · 4

Pace Ventureslisted by Pace VenturesBerlin · $550K – $1.6Mvia Marius Swart · inferred
ZAKA VClisted by ZAKA VCSan Francisco
KdT VenturesreportedAustin · $500K – $3M

How we know: the VCSheet dataset · Not right? Tell us

Frequently asked questions

What does Creasallis do?
Creasallis develops CreaTap, a patented "plug-and-play" antibody modification technology that improves the penetration of antibody-based drugs into solid tumours, applicable to monoclonal, bispecific, and antibody-drug conjugates. It serves biopharmaceutical companies developing oncology therapeutics and is also building its own suite of antibody therapeutics with enhanced tumour penetration.
Who founded Creasallis?
Creasallis was founded by Zahra Jawad.
Who are Creasallis's investors?
Creasallis's investors include BlueYard Capital, Pace Ventures, ZAKA VC, KdT Ventures.